Your browser doesn't support javascript.
loading
Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study.
Hua, Yijia; Li, Wei; Jin, Nan; Cai, Dongyan; Sun, Jie; Sun, Chunxiao; Yang, Fan; Wu, Xinyu; Huang, Xiang; Wang, Biyun; Yin, Yongmei.
Affiliation
  • Hua Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Li W; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Jin N; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Cai D; Department of Medical Oncology, The Affiliated Hospital of Jiangnan University Wuxi, China.
  • Sun J; Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Sun C; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Yang F; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wu X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Huang X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wang B; Department of Breast Cancer and Urological Medical Oncology, Fudan University Shanghai Cancer Center.
  • Yin Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.
Ther Adv Med Oncol ; 14: 17588359221085232, 2022.
Article de En | MEDLINE | ID: mdl-35356262

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials Langue: En Journal: Ther Adv Med Oncol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials Langue: En Journal: Ther Adv Med Oncol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni